LianBio
LianBio is grouped at the issuer level across 1 linked ticker lifecycle, combining public listing, delisting, source, and shareholder outcome records from the archive.
Lifecycle Map
Issuer enters the archive
Oct 1, 2021LianBio is represented as an issuer-level entity with 1 linked public-market ticker lifecycle.
Delisting event
Mar 11, 2024Removed from listing - SEC Form 25 filed.
SourceLIANY stopped trading
Mar 11, 2024LIANY is linked to LianBio and ended with final status "private".
Source
Entity Graph
LianBioissuedLIANY
LIANYlisted onNASDAQ
LIANYresulted incash payout
Source-Backed Claims
- LianBio's Board of Directors completed its strategic review and determined to wind down the Company's operations on February 13, 2024.8-K
- The wind down will include the sale of remaining pipeline assets, delisting of American Depositary Shares (ADSs) from Nasdaq, and workforce reductions.8-K
- LianBio announced a special cash dividend of $4.80 per Ordinary Share, equating to an aggregate of approximately $528 million.8-K
- On February 9, 2024, LianBio's Board approved a reduction in force of over 50 full-time employees, approximately 50% of its employee base.8-K
- LianBio expects the full wind down of operations and termination of employees to be substantially completed by the end of 2024.8-K
- The Company expects to incur approximately $17.2 million in costs related to the wind down, primarily for employee severance and retention bonuses.8-K
- As part of the wind down, LianBio intends to file a Form 25 with the SEC on or about March 8, 2024 to effect voluntary delisting of its ADSs from Nasdaq.8-K
- LianBio anticipates that trading of its ADSs on Nasdaq will cease on or about March 18, 2024.8-K
Associated Tickers
Public-market security lifecycles tied to this issuer record.